MK-5172 hydrate

Catalog No. A15166

MK-5172 is a novel P2-P4 quinoxaline macrocyclic HCV NS3/4a protease inhibitor currently in clinical development.
Catalog Num A15166
M. Wt 784.92
Formula C38H52N6O10S
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 1350462-55-3
Synonyms MK5172 hydrate, MK 5172 hydrate
SMILES CC(C)(C)C1C(=O)N2CC(CC2C(=O)NC3(CC3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCCC7CC7OC(=O)N1.O
MK-5172 is a novel P2-P4 quinoxaline macrocyclic HCV NS3/4a protease inhibitor currently in clinical development.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 12.74 mL 63.7 mL 127.4 mL
0.5 mM 2.55 mL 12.74 mL 25.48 mL
1 mM 1.27 mL 6.37 mL 12.74 mL
5 mM 0.25 mL 1.27 mL 2.55 mL

*The above data is based on the productmolecular weight 784.92. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.